# A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features

> **NCT04209166** · NA · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 780 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
- **DRUG:** SSRIs/SNRIs+Mood Stabilizer
- **DRUG:** SSRIs/SNRIs+Quetiapine
- **DRUG:** Usual Treatment

## Key facts

- **NCT ID:** NCT04209166
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-12
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 780 (ESTIMATED)
- **Last updated:** 2019-12-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04209166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04209166, "A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04209166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*